Skip to main content
Signal8

Catalyst4, Inc.

SEC insider (Form 3/4/5 filer). CIK 0001900201. 10% Owner at MapLight Therapeutics, Inc. (MLPT). 7 reported Form 4/5 transactions since Sep 2024; latest on Aug 14, 2026. Located in PALO ALTO, CA.

Companies Catalyst4, Inc. has filed insider reports for

  • MapLight Therapeutics, Inc. (MLPT): 10% Owner
Catalyst4, Inc. profile photo

Catalyst4, Inc.

CIK: 0001900201

Transaction Breakdown

Open Market Buys (P)6 (85.7%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (14.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

MapLight Therapeutics, Inc. logo
MLPT

MapLight Therapeutics, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • MapLight Therapeutics, Inc. logo
    MLPT

    MapLight Therapeutics, Inc.

    Aug 14, 2026
    Purchase
    Indirect
    4.4M shares at avg. $11.38$50.1M
  • MapLight Therapeutics, Inc. logo
    MLPT

    MapLight Therapeutics, Inc.

    Jul 30, 2026
    Purchase
    Indirect
    1M shares at avg. $13.00$13.0M
  • MapLight Therapeutics, Inc. logo
    MLPT

    MapLight Therapeutics, Inc.

    Jul 29, 2026
    Purchase
    Indirect
    3K shares at avg. $12.63$38K
  • MapLight Therapeutics, Inc. logo
    MLPT

    MapLight Therapeutics, Inc.

    Jul 28, 2026
    Purchase
    Indirect
    141.1K shares at avg. $10.74$1.5M
  • MapLight Therapeutics, Inc. logo
    MLPT

    MapLight Therapeutics, Inc.

    Jul 28, 2026
    Purchase
    Indirect
    65.1K shares at avg. $11.69$761K
  • MapLight Therapeutics, Inc. logo
    MLPT

    MapLight Therapeutics, Inc.

    Oct 28, 2025
    Conversion
    Indirect
    14.3M shares-
  • MapLight Therapeutics, Inc. logo
    MLPT

    MapLight Therapeutics, Inc.

    Oct 28, 2025
    Purchase
    Indirect
    5.4M shares at avg. $17.00$92.5M

1-7 of 7